Poseida Therapeutics Appoints Mark Gergen as Chief Business Officer and Chief Financial Officer

SAN DIEGO, Feb. 28, 2018 -- (Healthcare Sales & Marketing Network) -- Poseida Therapeutics Inc. (“Poseida”), a San Diego-based company translating best-in-class gene engineering technologies into lifesaving cell therapies, today announced that Mark J. Gerg... Biopharmaceuticals, Oncology, Personnel Poseida Therapeutics, CAR T-cell, immunotherapy, multiple myeloma
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news